Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis

Overview of attention for article published in Neurological Research and Practice, November 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 17,409 followers.

RT @Brandon_Beaber: How effective is mayzent in SPMS in the real world? This observational study on 227 PwMS found that 64.8% were stable,…

01 Dec 2022

Reply Repost Favourite

RT @Brandon_Beaber: How effective is mayzent in SPMS in the real world? This observational study on 227 PwMS found that 64.8% were stable,…

30 Nov 2022

Reply Repost Favourite

How effective is mayzent in SPMS in the real world? This observational study on 227 PwMS found that 64.8% were stable, 21.4% improved, though some experienced progression and 31.2% stopped treatment for various reasons. https://t.co/AphCJiu6fi https://t.c

30 Nov 2022

Reply Repost Favourite

https://t.co/nuwahXkPsg

08 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.